TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 14563899

Group type: EXPERIMENTAL
Intervention: co-amoxiclav 2000/125 mg twice daily
Number of subjects: 230

Group type: COMPARATOR
Intervention: co-amoxiclav 875/125 mg three times daily
Number of subjects: 230
Study: 11194410

Group type: EXPERIMENTAL
Intervention: Pictures of objects during encoding
Number of subjects: 0

Group type: COMPARATOR
Intervention: Words denoting objects during encoding
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Recognition of objects encoded as pictures
Number of subjects: 0

Group type: COMPARATOR
Intervention: Recognition of objects encoded as words
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Semantic encoding specific to pictures
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Task-specific involvement across pictures and words
Number of subjects: 0
Study: 9002789

Group type: EXPERIMENTAL
Intervention: Z100
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Herculite XR
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Clearfil Photo Posterior
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Heliomolar RO
Number of subjects: 120
Study: 1480807

Group type: EXPERIMENTAL
Intervention: Ivermectin 100 mcg/kg
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Diethylcarbamazine (DEC) 3 mg/kg
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Diethylcarbamazine (DEC) 6 mg/kg
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Diethylcarbamazine (DEC) 3 mg/kg (3 successive semi-annual doses)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Ivermectin
Number of subjects: 58

Group type: COMPARATOR
Intervention: Diethylcarbamazine (DEC)
Number of subjects: 58
Study: 6529168

Group type: EXPERIMENTAL
Intervention: 50 mg of trimipramine in the evening
Number of subjects: 428

Group type: EXPERIMENTAL
Intervention: 10 mg of trimipramine three times daily
Number of subjects: 428

Group type: EXPERIMENTAL
Intervention: Trimipramine
Number of subjects: 428

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 428
Study: 31138860

Group type: EXPERIMENTAL
Intervention: Narrowband UVB phototherapy (24 sessions over 8 weeks)
Number of subjects: 20
Study: 28549014

Group type: EXPERIMENTAL
Intervention: Robot-assisted surgery
Number of subjects: 163

Group type: COMPARATOR
Intervention: Laparoscopic surgery
Number of subjects: 163
Study: 27385349

Group type: EXPERIMENTAL
Intervention: Healive
Number of subjects: 400

Group type: COMPARATOR
Intervention: Havrix
Number of subjects: 400
Study: 24643403

Group type: EXPERIMENTAL
Intervention: landiolol
Number of subjects: 200

Group type: COMPARATOR
Intervention: digoxin
Number of subjects: 200
Study: 22987022

Group type: EXPERIMENTAL
Intervention: Atomoxetine 80 mg daily followed by 100 mg daily for 5 days
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Atomoxetine 80 mg
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Atomoxetine 80 mg and 100 mg
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Atomoxetine
Number of subjects: 20
Study: 20202633

Group type: EXPERIMENTAL
Intervention: Interactive and tailored education
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 0
Study: 17999227

Group type: EXPERIMENTAL
Intervention: Negative feedback on initial task (picture-matching)
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Positive feedback on initial task (picture-matching)
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Low self-esteem group
Number of subjects: 66
Study: 16270222

Group type: EXPERIMENTAL
Intervention: Single-dose clindamycin (600 mg 1 hour before surgery)
Number of subjects: 124

Group type: COMPARATOR
Intervention: 24-hour clindamycin prophylaxis (600 mg 1 hour before surgery, followed by 300 mg every 6 hours)
Number of subjects: 124
Study: 12358676

Group type: EXPERIMENTAL
Intervention: Naloxone (intravenous bolus followed by continuous infusion)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 9697988

Group type: EXPERIMENTAL
Intervention: Continuous intravenous (Ci.v.) IL-2, n = 5
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Subcutaneous infusions of polyethylene glycol-modified (PEG) IL-2, n = 7
Number of subjects: 16

Group type: COMPARATOR
Intervention: Anti-viral therapy alone, n = 4
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: All treatment arms (Ci.v. IL-2, PEG IL-2, anti-viral therapy)
Number of subjects: 16
Study: 9343594

Group type: EXPERIMENTAL
Intervention: Perceptual Maze Test (PMT)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Motor control (SHAM)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Rest condition
Number of subjects: 8
Study: 2759955

Group type: EXPERIMENTAL
Intervention: Air breathing
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: 15% O2 breathing
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: 12% O2 breathing
Number of subjects: 6
Study: 266407

Group type: EXPERIMENTAL
Intervention: Active immunotherapy (AI)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Maintenance chemotherapy
Number of subjects: 20
Study: 31938877

Group type: EXPERIMENTAL
Intervention: Varenicline
Number of subjects: 173

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 173

Group type: EXPERIMENTAL
Intervention: Both treatment arms
Number of subjects: 173
Study: 27810284

Group type: EXPERIMENTAL
Intervention: Mindfulness and gratitude based intervention (4 times a week for 3 weeks)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Mindfulness and gratitude based intervention
Number of subjects: 46

Group type: COMPARATOR
Intervention: Control condition (treatment-as-usual)
Number of subjects: 46
Study: 26851697

Group type: EXPERIMENTAL
Intervention: 10mg of hydrocortisone
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study: 25078387

Group type: EXPERIMENTAL
Intervention: TIV/AS03
Number of subjects: 192

Group type: COMPARATOR
Intervention: TIV
Number of subjects: 192
Study: 22952691

Group type: EXPERIMENTAL
Intervention: Internet-based guided self-help problem-solving therapy (PST), consisting of 5 weekly lessons, supported by e-mail
Number of subjects: 45

Group type: COMPARATOR
Intervention: Waiting list control group (WL)
Number of subjects: 45
Study: 21057570

Group type: EXPERIMENTAL
Intervention: Primary tumors with β-catenin expression
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Reduced membrane expression of β-catenin
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Cytoplasmic localization of β-catenin
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Membrane β-catenin expression in ALNM
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Re-expression of β-catenin in ALNM
Number of subjects: 65
Study: 17365243

Group type: EXPERIMENTAL
Intervention: IR GRE imaging with gadoversetamide (0.2 or 0.3 mmol/kg)
Number of subjects: 43

Group type: COMPARATOR
Intervention: SSFP imaging
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: IR GRE imaging
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Both SSFP and IR GRE techniques
Number of subjects: 43
Study: 15127339

Group type: EXPERIMENTAL
Intervention: Miltefosine (2.5 mg/kg per day orally for 28 days)
Number of subjects: 124

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 124
Study: 11868759

Group type: EXPERIMENTAL
Intervention: Telithromycin 800 mg once daily for 5 days (n = 198)
Number of subjects: 395

Group type: COMPARATOR
Intervention: Penicillin V 500 mg three times daily for 10 days (n = 197)
Number of subjects: 395
Study: 9558688

Group type: EXPERIMENTAL
Intervention: Metoprolol (200 mg/day)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Nadolol (80 mg/day)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 7889960

Group type: EXPERIMENTAL
Intervention: Cefprozil 30 mg/kg/day (b.i.d.)
Number of subjects: 1279

Group type: COMPARATOR
Intervention: Amoxicillin-clavulanate 40 mg/kg/day (t.i.d.)
Number of subjects: 1279

Group type: EXPERIMENTAL
Intervention: Cefprozil
Number of subjects: 1279

Group type: COMPARATOR
Intervention: Amoxicillin-clavulanate
Number of subjects: 1279

Group type: COMPARATOR
Intervention: Cefaclor 40 mg/kg/day (t.i.d.)
Number of subjects: 1279

Group type: COMPARATOR
Intervention: Cefixime 8 mg/kg/day (q.d.)
Number of subjects: 1279
Study: 3116996

Group type: EXPERIMENTAL
Intervention: Labetalol
Number of subjects: 176

Group type: COMPARATOR
Intervention: Methyldopa
Number of subjects: 176
Study: 30468942

Group type: EXPERIMENTAL
Intervention: Cognitive training enhancing basic executive skills
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control group (no training)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Cognitive training
Number of subjects: 36
Study: 27645350

Group type: EXPERIMENTAL
Intervention: Very-low-fat, plant-based diet
Number of subjects: 61

Group type: COMPARATOR
Intervention: Wait-listed control group
Number of subjects: 61
Study: 24613160

Group type: EXPERIMENTAL
Intervention: Off-pump coronary artery bypass surgery
Number of subjects: 900

Group type: COMPARATOR
Intervention: On-pump coronary artery bypass surgery
Number of subjects: 900

Group type: COMPARATOR
Intervention: Comparison of graft patency between off-pump and on-pump
Number of subjects: 900
Study: 21732976

Group type: EXPERIMENTAL
Intervention: Vanillin odour exposure
Number of subjects: 20

Group type: COMPARATOR
Intervention: No vanillin odour exposure (Control)
Number of subjects: 20
Study: 19939441

Group type: EXPERIMENTAL
Intervention: Diindolylmethane (DIM) at approximately 2 mg/kg/day for 12 weeks
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Diindolylmethane (DIM)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Placebo (defatted rice bran)
Number of subjects: 64
Study: 17567538

Group type: EXPERIMENTAL
Intervention: Polyglycolide acid and trimethylene carbonate (Seamguard) used (group 1, n = 24)
Number of subjects: 48

Group type: COMPARATOR
Intervention: No intervention (group 2, n = 24)
Number of subjects: 48
Study: 16280438

Group type: EXPERIMENTAL
Intervention: 8 servings/d of carotenoid-rich vegetables and fruit
Number of subjects: 100

Group type: COMPARATOR
Intervention: 2 servings/d of carotenoid-rich vegetables and fruit
Number of subjects: 100
Study: 11986916

Group type: EXPERIMENTAL
Intervention: Nifedipine GITS (osmotic pump)
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: Nifedipine slow release microgranules (NMG)
Number of subjects: 91
Study: 7586949

Group type: EXPERIMENTAL
Intervention: 100 mg cimetidine
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 600 mg cimetidine
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 1200 mg cimetidine
Number of subjects: 12
Study: 2172934

Group type: EXPERIMENTAL
Intervention: Nedocromil
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 208429

Group type: EXPERIMENTAL
Intervention: theophylline-ephedrine combination (theophylline 90 mg, ephedrine 16 mg and phenobarbital 25 mg in an immediate release layer and theophylline 90 mg and ephedrine 32 mg in a sustained release layer)
Number of subjects: 10

Group type: COMPARATOR
Intervention: terbutaline (5 mg three times daily)
Number of subjects: 10
Study: 30664472

Group type: EXPERIMENTAL
Intervention: iCanCope app
Number of subjects: 60
Study: 27787681

Group type: EXPERIMENTAL
Intervention: Nurse-led sexual rehabilitation intervention
Number of subjects: 20
Study: 27488266

Group type: EXPERIMENTAL
Intervention: Intervention group (cognitive-behavioral model, 8 group sessions of 45 min each)
Number of subjects: 342

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 342

Group type: EXPERIMENTAL
Intervention: Intervention group
Number of subjects: 342
Study: 23876893

Group type: EXPERIMENTAL
Intervention: TheraBites (group 1)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Stacked tongue depressors (group 2)
Number of subjects: 22
Study: 21128036

Group type: EXPERIMENTAL
Intervention: Iliocapsularis muscle in Group I (dysplastic hips)
Number of subjects: 85

Group type: COMPARATOR
Intervention: Iliocapsularis muscle in Group II (excessive acetabular coverage)
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Fatty infiltration in Group I (dysplastic hips)
Number of subjects: 85

Group type: COMPARATOR
Intervention: Fatty infiltration in Group II (excessive acetabular coverage)
Number of subjects: 85
Study: 19955953

Group type: EXPERIMENTAL
Intervention: Graduated compression stockings for 6 months
Number of subjects: 14

Group type: COMPARATOR
Intervention: Best supportive care
Number of subjects: 14
Study: 17935764

Group type: EXPERIMENTAL
Intervention: 300-index of reactivity (IR) dose
Number of subjects: 628

Group type: EXPERIMENTAL
Intervention: 500-index of reactivity (IR) dose
Number of subjects: 628

Group type: COMPARATOR
Intervention: 100-index of reactivity (IR) dose
Number of subjects: 628

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 628
Study: 15016256

Group type: EXPERIMENTAL
Intervention: 1% metronidazole gel (MG, n=19)
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: 1% chlorhexidine gel (CG, n=20)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Placebo gel (PG, n=24)
Number of subjects: 63
Study: 11716994

Group type: EXPERIMENTAL
Intervention: Continuous transdermal 17beta‐estradiol 50 mcg/die plus acetate nomegestrolo 5 mg/die sequentially added for 12 days per month (Group A)
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: Continuous transdermal 17beta‐estradiol 50 mcg/die plus acetate nomegestrolo 2.5 mg/die added every day (Group B)
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: Continuous transdermal 17beta‐estradiol 50 mcg/die (Group C)
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: Tibolone 2.5 mg/die (Group D)
Number of subjects: 121

Group type: COMPARATOR
Intervention: No medication (Control Group E)
Number of subjects: 121
Study: 9426019

Group type: COMPARATOR
Intervention: Atrial pacing (true and false)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Ventricular pacing (true and false)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: True ventricular pacing
Number of subjects: 16

Group type: COMPARATOR
Intervention: False ventricular pacing
Number of subjects: 16
Study: 8021039

Group type: EXPERIMENTAL
Intervention: Dental gel
Number of subjects: 0

Group type: COMPARATOR
Intervention: Dentifrices (three types)
Number of subjects: 0
Study: 2530547

Group type: EXPERIMENTAL
Intervention: Cefixime 400 mg/day (single daily dose)
Number of subjects: 431

Group type: EXPERIMENTAL
Intervention: Cefixime 400 mg/day (two divided doses)
Number of subjects: 431

Group type: COMPARATOR
Intervention: Cefixime (both regimens)
Number of subjects: 431
Study: 1190691

Group type: EXPERIMENTAL
Intervention: Vasectomy and irrigation of distal vasa with acid Kystosol solution
Number of subjects: 90

Group type: COMPARATOR
Intervention: Vasectomy alone
Number of subjects: 90
Study: 29470691

Group type: EXPERIMENTAL
Intervention: Whey hydrolysate (WH)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Caseinate (CAS)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Carbohydrate (CHO)
Number of subjects: 27
Study: 29798253

Group type: EXPERIMENTAL
Intervention: Preoperative inflatable heating blanket (A group, n=20)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Warmed irrigation (B group, n=20)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (C group, n=20)
Number of subjects: 60
Study: 25959002

Group type: EXPERIMENTAL
Intervention: Intravenous (IV) chemotherapy
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: Oral chemotherapy
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: Overall chemotherapy (both IV and oral)
Number of subjects: 125
Study: 23331924

Group type: EXPERIMENTAL
Intervention: Cervical cerclage with cervical occlusion
Number of subjects: 309

Group type: COMPARATOR
Intervention: Cervical cerclage without cervical occlusion
Number of subjects: 309

Group type: EXPERIMENTAL
Intervention: Cervical occlusion with cerclage
Number of subjects: 309
Study: 21726499

Group type: EXPERIMENTAL
Intervention: Clindox® 150 mg capsule (test)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Dalacin C® 150 mg capsule (reference)
Number of subjects: 24
Study: 19531217

Group type: EXPERIMENTAL
Intervention: Exemestane (25 mg/day)
Number of subjects: 411

Group type: COMPARATOR
Intervention: Observation
Number of subjects: 411
Study: 16707074

Group type: EXPERIMENTAL
Intervention: Conventional antipsychotic drugs
Number of subjects: 363

Group type: COMPARATOR
Intervention: New atypical drugs
Number of subjects: 363

Group type: EXPERIMENTAL
Intervention: Clozapine
Number of subjects: 363

Group type: COMPARATOR
Intervention: New atypical drugs (band 2)
Number of subjects: 363
Study: 15531010

Group type: EXPERIMENTAL
Intervention: 4 NaP tablets (1.5 g NaP/tablet) each morning for 28 days (group A)
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: 8 NaP tablets (1.5 g NaP/tablet) each morning for 28 days (group B)
Number of subjects: 43
Study: 11747148

Group type: EXPERIMENTAL
Intervention: 4 Fr catheters
Number of subjects: 410

Group type: COMPARATOR
Intervention: 6 Fr catheters
Number of subjects: 410
Study: 9430569

Group type: EXPERIMENTAL
Intervention: Single-incision technique
Number of subjects: 40

Group type: COMPARATOR
Intervention: Two-incision technique
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Both techniques
Number of subjects: 40
Study: 7986979

Group type: EXPERIMENTAL
Intervention: ACP-2200 (automatic non-invasive arterial pressure monitor)
Number of subjects: 86

Group type: COMPARATOR
Intervention: Manual apparatus (mercury sphygmomanometer)
Number of subjects: 86
Study: 2900351

Group type: EXPERIMENTAL
Intervention: Annual screening by clinical examination of the breast with mammography in alternate years for 45,841 women
Number of subjects: 127117

Group type: COMPARATOR
Intervention: Teaching in breast self‐examination for 63,636 women
Number of subjects: 127117

Group type: COMPARATOR
Intervention: Comparison population of 127,117 women with no extra services provided
Number of subjects: 127117
Study: 25907673

Group type: EXPERIMENTAL
Intervention: Droxidopa (200 to 600 mg TID)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Droxidopa plus Carbidopa (25 or 50 mg TID)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Co-treatment (Droxidopa + Carbidopa)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 28074482

Group type: EXPERIMENTAL
Intervention: Remote ischaemic preconditioning (RIPC)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Control (no RIPC)
Number of subjects: 6
Study: 26234543

Group type: EXPERIMENTAL
Intervention: Self-Adjusting File (SAF; ReDent-Nova)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Twisted File Adaptive (TFA; SybronEndo)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Twisted File Adaptive (TFA) with Passive Ultrasonic Irrigation (PUI)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Self-Adjusting File (SAF)
Number of subjects: 48
Study: 23142449

Group type: EXPERIMENTAL
Intervention: Ceramic-on-ceramic bearing (CERAMIC), n = 48
Number of subjects: 92

Group type: COMPARATOR
Intervention: Ceramic-on-highly-crosslinked-polyethylene bearing (POLYETHYLENE), n = 44
Number of subjects: 92

Group type: COMPARATOR
Intervention: Ceramic-on-highly-crosslinked-polyethylene bearing (POLYETHYLENE)
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Ceramic-on-ceramic bearing (CERAMIC)
Number of subjects: 92
Study: 21173013

Group type: EXPERIMENTAL
Intervention: Anakinra (2 mg/kg subcutaneous daily, maximum 100 mg)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Anakinra
Number of subjects: 24
Study: 18294480

Group type: EXPERIMENTAL
Intervention: Weight loss > 5%
Number of subjects: 1706

Group type: COMPARATOR
Intervention: Weight loss <= 5%
Number of subjects: 1706

Group type: EXPERIMENTAL
Intervention: Weight change (not specified)
Number of subjects: 1706
Study: 16172149

Group type: EXPERIMENTAL
Intervention: r-hLH (lutropin alfa) 75 IU s.c. plus r-hFSH
Number of subjects: 114

Group type: COMPARATOR
Intervention: r-hFSH alone
Number of subjects: 114
Study: 12563620

Group type: COMPARATOR
Intervention: Neoral (cyclosporine) alone
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Neoral (cyclosporine) with olestra (0.35 g/kg, max 16 g)
Number of subjects: 7
Study: 10694769

Group type: EXPERIMENTAL
Intervention: Daily oral iron supplementation (2-3 mg of elemental iron per kg of body weight) for 3 months
Number of subjects: 163

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 163

Group type: EXPERIMENTAL
Intervention: Daily oral iron supplementation
Number of subjects: 163
Study: 9181765

Group type: EXPERIMENTAL
Intervention: Surgery (group I)
Number of subjects: 113

Group type: COMPARATOR
Intervention: Medical treatment (group II)
Number of subjects: 113
Study: 8451344

Group type: EXPERIMENTAL
Intervention: Rational-Emotive Therapy
Number of subjects: 141

Group type: COMPARATOR
Intervention: Auditory subliminal stimulation
Number of subjects: 141

Group type: EXPERIMENTAL
Intervention: Combined treatment (Rational-Emotive Therapy + Auditory subliminal stimulation)
Number of subjects: 141

Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 141
Study: 3488384

Group type: EXPERIMENTAL
Intervention: 1000 IU vitamin D3 daily (group +D)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (group -D)
Number of subjects: 40
Study: 29804929

Group type: EXPERIMENTAL
Intervention: olanzapine or risperidone
Number of subjects: 694

Group type: EXPERIMENTAL
Intervention: ABLs below RR
Number of subjects: 694

Group type: EXPERIMENTAL
Intervention: ABLs within/above RR
Number of subjects: 694
Study: 26584454

Group type: EXPERIMENTAL
Intervention: 100 mg Careless™
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 300 mg Careless™
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Careless™ (3000 µg/mL)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Careless™ (1500 µg/mL)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Careless™ (300 µg/mL)
Number of subjects: 10
Study: 23746264

Group type: EXPERIMENTAL
Intervention: Mean UFC levels from samples 1 and 2
Number of subjects: 152

Group type: EXPERIMENTAL
Intervention: Mean UFC levels from samples 3 and 4
Number of subjects: 152

Group type: EXPERIMENTAL
Intervention: Intrapatient coefficient of variation (CV) for mUFC using all four samples
Number of subjects: 152

Group type: EXPERIMENTAL
Intervention: Intrapatient CV for samples 1 and 2
Number of subjects: 152

Group type: EXPERIMENTAL
Intervention: Intrapatient CV for samples 3 and 4
Number of subjects: 152

Group type: EXPERIMENTAL
Intervention: Intrapatient CV for samples 1, 2, and 3
Number of subjects: 152

Group type: EXPERIMENTAL
Intervention: Variability in mUFC
Number of subjects: 152

Group type: EXPERIMENTAL
Intervention: Correlation between UFC and clinical features of hypercortisolism
Number of subjects: 152